Abstract
There is strong need to develop the current stratified practice of CVD management into a better personalized cardiovascular medicine, within a broad framework of global patient care. Clinical information obtained from history and physical examination, functional and imaging studies, biochemical biomarkers, genetic/epigenetic data, and pathophysiological insights into disease-driving processes need to be integrated into a new taxonomy of CVDs to allow personalized disease management. This has the potential for major health benefits for the population suffering from cardiovascular diseases.
Original language | English |
---|---|
Pages (from-to) | 3250-7 |
Number of pages | 8 |
Journal | European Heart Journal |
Volume | 35 |
Issue number | 46 |
DOIs | |
Publication status | Published - 7 Dec 2014 |
Keywords
- Biological Markers
- Cardiovascular Diseases
- Clinical Trials as Topic
- Diagnostic Imaging
- Diffusion of Innovation
- Evidence-Based Medicine
- Genomics
- Humans
- Individualized Medicine
- Needs Assessment
- Patient-Centered Care
- Risk Assessment